reinduction therapy consisting of cyclophosphamide ( 250 mg/m2 orally daily for 4 days ) followed by etoposide ( 250 mg/m2 iv daily for 3 days ) was administered to 14 children with refractory or recurrent acute nonlymphocytic leukemia .
C0010583
cyclophosphamide
C0023467
acute nonlymphocytic leukemia